NeoGenomics Inc.'s (NEO) Q1 2022 Results - Earnings Call Transcript

NeoGenomics, Inc. (NASDAQ:NASDAQ:NEO) Q1 2022 Earnings Conference Call April 27, 2022, 08:30 AM ET Company Participants Lynn Tetrault - Executive Chair & Principal Executive Officer...

Related Keywords

United States ,America ,Matt Sykes ,William Bonello ,Doug Vanoort ,Raymond James ,Alex Nowak ,Eli Lilly ,Russell Reynolds ,Dan Brennan ,Shashi Kulkarni ,David Sholehvar ,Doug Brown ,Charlie Eidson ,Lynn Tetrault ,Andrew Cooper ,Mark Massaro ,Puneet Souda ,Brian Weinstein ,William Blair ,Craig Hallum ,Morgan Stanley ,Company Participants ,Our La Jolla Lab ,Neogenomics Inc ,Goldman Sachs ,Washington University School Of Medicine ,Nasdaq ,Lab Services ,Derik De Bruin At Bank ,Exchange Commission ,Corporate Development ,Clinical Division ,Baylor College Of Medicine ,Quest Diagnostics ,Conference Call April ,Principal Executive ,Neogenomics First Quarter ,Executive Chair ,Fort Myers ,Bill Bonello ,Chief Financial Officer ,Chief Strategy ,Corporate Development Officer ,Chief Scientific Officer ,Executive Vice President ,Investor Relations ,Chief Executive Officer ,Chief Executive ,Clinical Division President ,Washington University ,Baylor College ,Cancer Genetics Elsevier Journal ,Derik De Bruin ,Process Excellence ,Radar Assay ,Precision Medicine Managers ,Tejas Savant ,